May 2, 2013, Darmstadt, Germany - Merck Millipore, the Life Science division of Merck, announced today the settlement of patent infringement disputes between Merck Millipore and W.L. Gore & Associates, Inc. in the United States District Court for the District of Massachusetts, United States District Court for the District of New Jersey, and United States District Court for the District of Delaware.
Gore has agreed to take a limited royalty-bearing license under U.S. Patent Nos. 7,293,744 and 7,927,316 and U.S. Reissue No. RE41,169, and their counterparts internationally in connection with its STA-PURE Fluid Sampling Systems and assemblies, Crimp and Cut tools, and STA-PURE Single Use Valve Systems and assemblies.
"Our customers rely on us to be technology leaders for innovation in biopharmaceutical production and, as such, Merck Millipore will continue to vigorously defend its intellectual property,” said Andrew Bulpin, Executive Vice President for Merck Millipore Process Solutions.
Merck Millipore is the Life Science division of Merck KGaA of Germany and offers a broad range of innovative, performance products, services and business relationships that enable our customers’ success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the Life Science Tools industry, Merck Millipore serves as a strategic partner to customers and helps advance the promise of life science.
Headquartered in Billerica, Massachusetts, the division has around 10,000 employees, operations in 66 countries and 2012 revenues of €2.6 billion Merck Millipore operates as EMD Millipore in the U.S. and Canada.
Note: Merck KGaA or Merck shall mean Merck KGaA, Darmstadt, Germany